As of Feb 17
| -0.23 / -4.14%|
The 6 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +50.09% increase from the last price of 5.33.
The current consensus among 7 polled investment analysts is to Buy stock in Pacific Biosciences of California Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.